- Home
- RVNC vs SXTC Comparison
RVNC vs SXTC Comparison
Compare RVNC & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- SXTC
- Stock Information
- Founded
- RVNC 1999
- SXTC 2005
- Country
- RVNC United States
- SXTC China
- Employees
- RVNC N/A
- SXTC N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- RVNC Health Care
- SXTC Health Care
- Exchange
- RVNC Nasdaq
- SXTC Nasdaq
- Market Cap
- RVNC 320.5M
- SXTC 1.6M
- IPO Year
- RVNC 2014
- SXTC 2019
- Fundamental
- Price
- RVNC $3.09
- SXTC $0.32
- Analyst Decision
- RVNC Hold
- SXTC
- Analyst Count
- RVNC 9
- SXTC 0
- Target Price
- RVNC $8.45
- SXTC N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- SXTC 1.7M
- Earning Date
- RVNC 11-07-2024
- SXTC 01-01-0001
- Dividend Yield
- RVNC N/A
- SXTC N/A
- EPS Growth
- RVNC N/A
- SXTC N/A
- EPS
- RVNC N/A
- SXTC N/A
- Revenue
- RVNC $256,945,000.00
- SXTC $1,928,497.00
- Revenue This Year
- RVNC $11.28
- SXTC N/A
- Revenue Next Year
- RVNC $27.21
- SXTC N/A
- P/E Ratio
- RVNC N/A
- SXTC N/A
- Revenue Growth
- RVNC 25.82
- SXTC N/A
- 52 Week Low
- RVNC $2.30
- SXTC $0.30
- 52 Week High
- RVNC $9.75
- SXTC $6.39
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- SXTC 33.98
- Support Level
- RVNC $3.06
- SXTC $0.39
- Resistance Level
- RVNC $3.09
- SXTC $0.36
- Average True Range (ATR)
- RVNC 0.11
- SXTC 0.05
- MACD
- RVNC 0.02
- SXTC -0.00
- Stochastic Oscillator
- RVNC 6.90
- SXTC 7.97
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.